USD
+$0.00
(+0.00%
)At Close (As of Nov 5, 2025)
$25.18M
Market Cap
-
P/E Ratio
-0.3
EPS
$1.13
52 Week High
$0.56
52 Week Low
HEALTHCARE
Sector
| Field | Value (USD) |
|---|---|
| Gross Profit | -$1M |
| Total Revenue | $33M |
| Cost Of Revenue | $34M |
| Costof Goods And Services Sold | $34M |
| Operating Income | -$21M |
| Selling General And Administrative | $14M |
| Research And Development | $674K |
| Operating Expenses | $20M |
| Investment Income Net | - |
| Net Interest Income | $878K |
| Interest Income | $1M |
| Interest Expense | $123K |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $7.6M |
| Income Before Tax | -$3.5M |
| Income Tax Expense | $8.4M |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$12M |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$3.4M |
| Ebitda | $4.2M |
| Net Income | -$12M |
| Field | Value (USD) |
|---|---|
| Total Assets | $161M |
| Total Current Assets | $73M |
| Cash And Cash Equivalents At Carrying Value | $4.2M |
| Cash And Short Term Investments | $4.2M |
| Inventory | $19M |
| Current Net Receivables | $8.8M |
| Total Non Current Assets | $87M |
| Property Plant Equipment | $87M |
| Accumulated Depreciation Amortization Ppe | - |
| Intangible Assets | - |
| Intangible Assets Excluding Goodwill | - |
| Goodwill | - |
| Investments | - |
| Long Term Investments | - |
| Short Term Investments | $40M |
| Other Current Assets | $753K |
| Other Non Current Assets | - |
| Total Liabilities | $74M |
| Total Current Liabilities | $8.8M |
| Current Accounts Payable | $4.3M |
| Deferred Revenue | - |
| Current Debt | - |
| Short Term Debt | $332K |
| Total Non Current Liabilities | $65M |
| Capital Lease Obligations | - |
| Long Term Debt | $900K |
| Current Long Term Debt | $332K |
| Long Term Debt Noncurrent | - |
| Short Long Term Debt Total | $1.2M |
| Other Current Liabilities | $3.8M |
| Other Non Current Liabilities | $64M |
| Total Shareholder Equity | $87M |
| Treasury Stock | - |
| Retained Earnings | $27M |
| Common Stock | -$13M |
| Common Stock Shares Outstanding | $30M |
| Field | Value (USD) |
|---|---|
| Operating Cashflow | -$12M |
| Payments For Operating Activities | - |
| Proceeds From Operating Activities | - |
| Change In Operating Liabilities | - |
| Change In Operating Assets | - |
| Depreciation Depletion And Amortization | $7.6M |
| Capital Expenditures | $1.4M |
| Change In Receivables | - |
| Change In Inventory | -$1.6M |
| Profit Loss | - |
| Cashflow From Investment | $3.7M |
| Cashflow From Financing | -$535K |
| Proceeds From Repayments Of Short Term Debt | - |
| Payments For Repurchase Of Common Stock | - |
| Payments For Repurchase Of Equity | - |
| Payments For Repurchase Of Preferred Stock | - |
| Dividend Payout | $230K |
| Dividend Payout Common Stock | $230K |
| Dividend Payout Preferred Stock | - |
| Proceeds From Issuance Of Common Stock | - |
| Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
| Proceeds From Issuance Of Preferred Stock | - |
| Proceeds From Repurchase Of Equity | $0 |
| Proceeds From Sale Of Treasury Stock | - |
| Change In Cash And Cash Equivalents | - |
| Change In Exchange Rate | - |
| Net Income | -$12M |
| Field | Value (USD) |
|---|---|
| Gross Profit | -$1M |
| Total Revenue | $33M |
| Cost Of Revenue | $34M |
| Costof Goods And Services Sold | $34M |
| Operating Income | -$21M |
| Selling General And Administrative | $14M |
| Research And Development | $674K |
| Operating Expenses | $20M |
| Investment Income Net | - |
| Net Interest Income | $878K |
| Interest Income | $1M |
| Interest Expense | $123K |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $7.6M |
| Income Before Tax | -$3.5M |
| Income Tax Expense | $8.4M |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$12M |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$3.4M |
| Ebitda | $4.2M |
| Net Income | -$12M |
Sector: HEALTHCARE
Industry: MEDICAL INSTRUMENTS & SUPPLIES
Retractable Technologies, Inc. (RVP) specializes in the design, development, manufacture, and marketing of safety syringes and other innovative medical products, aimed at enhancing patient safety and reducing needle-stick injuries. Headquartered in Little Elm, Texas, the company serves a diverse market across the United States, North America, and internationally, positioning itself as a key player in the healthcare sector. With a commitment to advancing medical safety solutions, Retractable Technologies continues to expand its product portfolio and strengthen its presence in the global healthcare landscape.